Brevan Howard Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
+36,567
| New | +$132K | ﹤0.01% | 1679 |
|
|
2024
Q4 | – | Sell |
-13,868
| Closed | -$46.5K | – | 1008 |
|
|
2024
Q3 | $46.5K | Buy |
+13,868
| New | +$46.5K | ﹤0.01% | 1042 |
|
|
2024
Q2 | – | Sell |
-20,809
| Closed | -$84.1K | – | 1017 |
|
|
2024
Q1 | $84.1K | Sell |
20,809
-4,908
| -19% | -$19.8K | ﹤0.01% | 861 |
|
|
2023
Q4 | $78.4K | Buy |
+25,717
| New | +$78.4K | ﹤0.01% | 930 |
|